HC seeks Centre's stand on challenge to ban on fixed dose combination drugs
The Delhi High Court has sought the stand of the Centre on a petition by a pharmaceutical company challenging the government's decision to ban manufacture, sale and distribution for human use certain Fixed Dose Combination (FDC) drugs. FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio. While issuing notice on three petitions by Glenmark Pharmaceuticals Ltd against the ban, the court directed the FDC drugs produced by the petitioners... Читать дальше...